The Effective Removal of Proinflammatory Cytokines by Continuous Hemofiltration with a Polymethylmethacrylate Membrane Following Severe Burn Injury: Report of Three Cases

Overview

Journal Surg Today

Specialty General Surgery

Date 1999 Sep 14

PMID 10483752

Citations 1

Authors

H Nakae

S Motoyama

S Kurosawa

H Inaba

Affiliations

Soon will be listed here.

Abstract

The serum levels of proinflammatory cytokines were investigated in three patients with severe burn injuries complicated by sepsis and pulmonary edema, who were treated with continuous hemofiltration (CHF) using a polymethylmethacrylate (PMMA) membrane. All patients had suffered burn injuries to more than 30% of their total body surface area (TBSA) and had burn indexes of 20 or more. Both interleukin (IL)-6 and tumor necrosis factor-alpha were detectable in one patient, while the serum IL-6 levels were elevated in the remaining two patients. The serum cytokines decreased 24 h after the initiation of CHF. Determinations of IL-6 in inflow and outflow blood samples as well as in the filtration fluid revealed that IL-6 was ultrafiltrated and/or adsorbed by the filter. Two of the three patients did not survive. Nevertheless, the results of this study indicate that since burn injuries are frequently associated with hypercytokinemia, the removal of cytokines by CHF with a PMMA membrane may be effective in the management of severe burn injuries.

Citing Articles

Hemofiltration for hyperbilirubinemia after left ventricular assist system implantation: report of four cases.

Miyagawa S, Nishimura M, Fukushima N, Matsumiya G, Fujino Y, Matsuda H Surg Today. 2008; 38(8):747-50.

PMID: 18668321 DOI: 10.1007/s00595-007-3731-1.

References

Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H . Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns. J Med. 1996; 27(1-2):57-71. View

Bagby G, Plessala K, Wilson L, Thompson J, Nelson S . Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis. 1991; 163(1):83-8. DOI: 10.1093/infdis/163.1.83. View

Heering P, Morgera S, Schmitz F, Schmitz G, Willers R, Schultheiss H . Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med. 1997; 23(3):288-96. DOI: 10.1007/s001340050330. View

Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H . Plasma tumour necrosis factor-alpha (TNF-alpha) levels in patients with burns. Burns. 1993; 19(2):124-7. DOI: 10.1016/0305-4179(93)90033-5. View

Endo S, Inada K, Nakae H, Arakawa N, Takakuwa T, Yamada Y . Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol. 1996; 91(3):347-56. View

Hirasawa H, Sugai T, Ohtake Y, Oda S, Matsuda K, Kitamura N . Blood purification for prevention and treatment of multiple organ failure. World J Surg. 1996; 20(4):482-6. DOI: 10.1007/s002689900076. View

Nijsten M, Hack C, Helle M, Ten Duis H, Klasen H, Aarden L . Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery. 1991; 109(6):761-7. View

Yamada Y, Endo S, Inada K . Plasma cytokine levels in patients with severe burn injury--with reference to the relationship between infection and prognosis. Burns. 1996; 22(8):587-93. DOI: 10.1016/s0305-4179(96)00052-6. View

Endo S, Inada K, Arakawa N, Yamada Y, Nakae H, Takakuwa T . Interleukin 11 levels in patients with disseminated intravascular coagulation. Res Commun Mol Pathol Pharmacol. 1996; 91(2):253-6. View

10.

. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20(6):864-74. View

11.

Nakae H, Endo S, Inada K, Yamada Y, Takakuwa T, Yoshida M . Plasma levels of endothelin-1 and thrombomodulin in burn patients. Burns. 1996; 22(8):594-7. DOI: 10.1016/s0305-4179(96)00063-0. View

12.

Livingston D, Mosenthal A, Deitch E . Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview. New Horiz. 1995; 3(2):257-66. View

13.

Schluter B, Konig B, Bergmann U, Muller F, Konig W . Interleukin 6--a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma. 1991; 31(12):1663-70. DOI: 10.1097/00005373-199112000-00017. View

14.

Nakae H, Endo S, Inada K, Yamashita H, Yamada Y, Takakuwa T . Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns. Burns. 1995; 21(6):422-6. DOI: 10.1016/0305-4179(95)00022-4. View

15.

Bellomo R, Tipping P, Boyce N . Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med. 1993; 21(4):522-6. DOI: 10.1097/00003246-199304000-00011. View

16.

Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P . Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?. Intensive Care Med. 1995; 21(2):169-76. DOI: 10.1007/BF01726541. View

17.

Sander A, Armbruster W, Sander B, Daul A, Lange R, Peters J . Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med. 1997; 23(8):878-84. DOI: 10.1007/s001340050425. View